US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Xtrackers Nifty 500 India ETF

23.07

+0.07000.30%

Post-market: 23.070.00000.00%16:10 EDT

Volume:2K

Turnover:56.63K

Market Cap:4.61M

PE:- -

High:23.28

Open:23.00

Low:23.00

Close:23.00

52wk High:27.40

52wk Low:20.52

Shares:200.00K

Float Shares:200.00K

Volume Ratio:15.02

T/O Rate:1.23%

Dividend:0.08

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Industrial Minerals calls crucial shareholder vote on Galleon Metals acquisition

Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program

Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers

Is HBM Holdings (SEHK:2142) Fully Valued After Its Asthma IND Approval?

Simply Wall St.

Central Bank of India Sells US Dollars in Forex Market to Bolster Rupee, According to Traders

South African Fund Manager with $47 Billion AUM Reduces AI Chip Holdings, Boosts Exposure to Indian Equities

OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme

Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models

HBM Holdings Wins NMPA IND Nod for Long-Acting Asthma Antibody HBM7575

ABBISKO-B Surges Over 5% on FDA Clearance for Investigational Drug Application of Oral Pan-KRAS Inhibitor

Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event

Atrium Therapeutics announces FDA clearance of ATR 1072 IND application

HAIXI PHARMA's HXP089 Project Receives NMPA Approval for Glioblastoma Clinical Trial Application

Haisco Pharmaceutical's China IND Application for Novel Inflammatory Drug Accepted

MT Newswires Live

Neurotech Secures FDA IND Clearance for NTI164, Bolstering Global ASD Strategy

Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026

Market Participants Report Indian Central Bank's Dollar Sales to Support Rupee

Abbisko Wins FDA IND Clearance for Pan-KRAS Cancer Drug ABSK211

Global funds return to Indian stocks with US$1 bil in buying

Ashutosh Joshi / Bloomberg

India Ratings Upgrades Vadilal Industries’ Credit Profile to IND A+

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/IND/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","market":"US","secType":"STK","nameCN":"Xtrackers Nifty 500 India ETF","latestPrice":23.065,"timestamp":1787601600000,"preClose":22.995,"halted":0,"volume":2451,"hourTrading":{"tag":"盘后","latestPrice":23.065,"preClose":23.065,"latestTime":"16:10 EDT","volume":7,"amount":161.455,"timestamp":1787602204733,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0030441400304414127,"floatShares":200001,"shares":200001,"eps":0,"marketStatus":"Post-Mkt","change":0.07,"latestTime":"08-24 18:41:01 EDT","open":23,"high":23.28,"low":23,"amount":56631,"amplitude":0.012177,"askPrice":34.49,"askSize":100,"bidPrice":16,"bidSize":2,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":22.995,"sharesOutstanding":200001,"nav":23.031,"aum":4606217.85,"dividendRate":0.003408,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":23.1,"preClose":22.995,"latestTime":"09:29 EDT","volume":206,"amount":4758.869860000001,"timestamp":1787578199043,"change":0.105,"changeRate":0.004566,"amplitude":0.004784},"postHourTrading":{"tag":"盘后","latestPrice":23.065,"preClose":23.065,"latestTime":"16:10 EDT","volume":7,"amount":161.455,"timestamp":1787602204733,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":15.018366},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","floatShares":200001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":15.018366,"shares":200001,"dividePrice":0.0786,"high":23.28,"amplitude":0.012177,"preClose":22.995,"low":23,"week52Low":20.515,"pbRate":"--","week52High":27.4,"institutionHeld":0,"latestPrice":23.065,"committee":-0.960784,"eps":0,"divideRate":0.003408,"volume":2451,"delay":0,"ttmEps":0,"open":23,"prevYearClose":24.78,"prevWeekClose":22.995,"prevMonthClose":22.885,"prevQuarterClose":22.88,"fiveDayClose":23.005,"twentyDayClose":22.495,"sixtyDayClose":22.475},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IND\",params:#limit:5,,,undefined,":[{"date":"2026-06-18","symbol":"IND","amount":0.07775,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Xtrackers Nifty 500 India ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IND\",market:\"US\",,,undefined,":[{"executeDate":"2026-06-18","recordDate":"2026-06-18","paymentDate":"2026-06-26","value":0.07775,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IND\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IND\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653667719","title":"Industrial Minerals calls crucial shareholder vote on Galleon Metals acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2653667719","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653667719?lang=en_us&edition=fundamental","pubTime":"2026-07-23 13:52","pubTimestamp":1784785964,"startTime":"0","endTime":"0","summary":"Industrial Minerals Limited ( ($AU:IND) ) has provided an update. Industrial Minerals Ltd has called a general meeting for 21 August 2026 in Pepper...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-calls-crucial-shareholder-vote-on-galleon-metals-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-calls-crucial-shareholder-vote-on-galleon-metals-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","MTX","RSBA","PICK","MRGR","IND","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653270035","title":"Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2653270035","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653270035?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:55","pubTimestamp":1784638500,"startTime":"0","endTime":"0","summary":"Silo continues to add technology assets as it expands its AI business and further develops its lead PTSD therapeutic candidate  AI agent platform prepares for commercial launch while SPC-15 regulatory","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/21/3330474/0/en/Silo-Pharma-Advances-Growth-Platforms-for-AI-Agent-Commercialization-and-Lead-PTSD-Drug-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","AIPO","DBB","BK4135","IND","VTHR","QTOC","CNS","ARTY","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653277003","title":"Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277003","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277003?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:00","pubTimestamp":1784635200,"startTime":"0","endTime":"0","summary":"Company receives positive pre-IND feedback from US FDA for CLD-401, indicating agreement on its current development strategy as it advances towards a first-in-human study; targeting dosing first patie","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/21/3330378/0/en/Calidi-Biotherapeutics-Provides-Mid-Year-Corporate-Update-and-Future-Key-Value-Drivers.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0828238088.HKD","SITC","IND","BK4548","BK4571","IE00B12V2V27.USD","BK4565","LU0269904917.USD","IE00BYTNYN87.SGD","LU0456842615.SGD","LU0509642566.USD","SG9999011746.SGD","IE00BYQNZ168.SGD","LU0359202008.SGD","BK4108","BK4509","BK4080","BK4552","TME","BK4563","BK4526","LU0359201612.USD","BMS","LU1023057109.AUD","BK4531","LU2039709279.SGD","01698","BK4535","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653627641","title":"Is HBM Holdings (SEHK:2142) Fully Valued After Its Asthma IND Approval?","url":"https://stock-news.laohu8.com/highlight/detail?id=2653627641","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653627641?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:16","pubTimestamp":1784629000,"startTime":"0","endTime":"0","summary":"HBM Holdings (SEHK:2142) is in focus after China’s National Medical Products Administration approved the Investigational New Drug application for HBM7575/SKB575, a long-acting bispecific antibody candidate for asthma co-developed with Kelun-Biotech.\nSee our latest analysis for HBM Holdings.\nThe IND approval appears to have reinforced interest in HBM Holdings, with the HK$11.96 share price supported by a 9.72% 1 month share price return and a very large 3 year total shareholder return, even...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/is-hbm-holdings-sehk2142-fully-valued-after-its-asthma-ind-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/is-hbm-holdings-sehk2142-fully-valued-after-its-asthma-ind-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","RAM","COPP","DRAL","02142","IND","DRMY","HBMX","DRMP","BK1583","MIC","BK4168","HBM","MUD","MUZ","DISK","MUU","MULL","BK4588","DCF","DRAM","MUYY","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127672518","title":"Central Bank of India Sells US Dollars in Forex Market to Bolster Rupee, According to Traders","url":"https://stock-news.laohu8.com/highlight/detail?id=1127672518","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127672518?lang=en_us&edition=fundamental","pubTime":"2026-07-20 12:00","pubTimestamp":1784520022,"startTime":"0","endTime":"0","summary":"According to traders with knowledge of the matter, the Reserve Bank of India has been selling US dollars in both offshore and onshore foreign exchange markets to support the rupee. These traders...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","FLIBF","IND","INCO","INDE","NDIA","INDA","UDN","NFTY","BK4523","INDY","IMVP","INDL","INQQ","SMIN","SCIN","FLIN","UUP","EPI","BK4588","IOPP","PIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117398250","title":"South African Fund Manager with $47 Billion AUM Reduces AI Chip Holdings, Boosts Exposure to Indian Equities","url":"https://stock-news.laohu8.com/highlight/detail?id=1117398250","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117398250?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:52","pubTimestamp":1784278327,"startTime":"0","endTime":"0","summary":"A South African asset manager overseeing $47 billion has trimmed its investments in semiconductor manufacturers and increased its allocation to the Indian market, as market expectations for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIBU","LRNZ","WISE","AVEM","MFEM","AVS","KEMX","XCNY","INCO","XXCH","AVL","BCHI","AVGW","BK4523","BK4588","FLIBF","ALAI","DFAE","INDL","MEMX","SPEM","IND","INDA","EEMV","RWEM","PEMX","IMVP","SMIN","INDE","SCHE","AVGX","EPI","XSOE","BK4550","AIFD","BKF","VEU","DEXC","XCEM","EQLT","BK4585","SEEM","AIVC","EET","INDH","EEMA","NFTY","STXE","AVGU","XC","INQQ","INDY","FLIN","MEM","QLVE","NDIA","SCIN","QEMM","AVGG","HEEM","ASIA","FAI","PIN","EMXC","IOPP","FEMR","BBEM","BKEM","AIS","GLIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651464104","title":"OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=2651464104","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651464104?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:00","pubTimestamp":1784199600,"startTime":"0","endTime":"0","summary":"New client programme to be supported from OXB’s FDA-approved, commercial scale viral vector manufacturing facility in Durham, North Carolina, underscoring increasing global demand for OXB’s end-to-end","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/16/3328316/0/en/OXB-Selected-as-GMP-Manufacturing-Partner-to-Support-Manufacturing-of-Plowshare-Therapies-AAV-Gene-Therapy-Programme.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EES","BK4139","JDOC","SYNB","IND","BK4585","BK4588","CDMO","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651246501","title":"Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2651246501","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651246501?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:05","pubTimestamp":1784120700,"startTime":"0","endTime":"0","summary":"Data show clade IIb from 2022 outbreak is 100 to 100,000-fold less virulent than clade IIa from 2003 outbreak  Three new models for investigating mpox infection and pathogenesis identified Tonix is ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/15/3327818/28908/en/Tonix-Pharmaceuticals-Announces-Publication-in-the-Peer-Reviewed-Journal-of-Virology-Assessing-Virulence-of-the-2022-Outbreak-Strain-of-Mpox-in-New-Animal-Models.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4583","IND","TNXP","BK4188","RDC","BK4135","CNS","ASM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651454611","title":"HBM Holdings Wins NMPA IND Nod for Long-Acting Asthma Antibody HBM7575","url":"https://stock-news.laohu8.com/highlight/detail?id=2651454611","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651454611?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:07","pubTimestamp":1784110075,"startTime":"0","endTime":"0","summary":"HBM Holdings Ltd. ( ($HK:2142) ) just unveiled an announcement. HBM Holdings Ltd. reported that China’s National Medical Products Administration ha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hbm-holdings-wins-nmpa-ind-nod-for-long-acting-asthma-antibody-hbm7575?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hbm-holdings-wins-nmpa-ind-nod-for-long-acting-asthma-antibody-hbm7575?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND","DRAM","COPP","HBM","MUU","DRAL","BK4588","RAM","MULL","MUD","BK4168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140504842","title":"ABBISKO-B Surges Over 5% on FDA Clearance for Investigational Drug Application of Oral Pan-KRAS Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=1140504842","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140504842?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:26","pubTimestamp":1784085985,"startTime":"0","endTime":"0","summary":"Shares of ABBISKO-B (HKEX: 02256) have risen by more than 5%. At the time of writing, the stock is up 5.53% to HKD 11.25, with a turnover of HKD 2.5452 million.The move follows a recent company...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","02256","LABU","IND","BK4588","BK1161","159938","09939","BK1515","IE00BPRC5H50.USD","IE00B543WZ88.USD","LU2778985437.USD","KCAI","IE00B5MMRT66.SGD","LU2476274308.USD","BK4585","BK1574","VXUS","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651738105","title":"Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2651738105","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651738105?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:00","pubTimestamp":1784030400,"startTime":"0","endTime":"0","summary":"–Expands pipeline with SNDX-4321, a novel, mutant-selective, allosteric EGFR inhibitor designed to address NSCLC patient populations with significant unmet needs – –SNDX-62122, a next-generation menin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/14/3326768/0/en/Syndax-to-Highlight-Late-Stage-Programs-and-Unveil-New-Pipeline-Assets-at-R-D-Event.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651172282","title":"Atrium Therapeutics announces FDA clearance of ATR 1072 IND application","url":"https://stock-news.laohu8.com/highlight/detail?id=2651172282","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651172282?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:40","pubTimestamp":1784025625,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics (RNA) announced that the FDA has cleared its investigational new drug, or IND, application allowing the company to move forward...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atrium-therapeutics-announces-fda-clearance-of-atr-1072-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atrium-therapeutics-announces-fda-clearance-of-atr-1072-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATR","BK4139","IND","BK4585","BK4588","RNA","LABU","IE0009354923.USD","BK4505","BK4126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116749786","title":"HAIXI PHARMA's HXP089 Project Receives NMPA Approval for Glioblastoma Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1116749786","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116749786?lang=en_us&edition=fundamental","pubTime":"2026-07-14 17:13","pubTimestamp":1784020411,"startTime":"0","endTime":"0","summary":"The company's self-developed HXP089 project, intended for the treatment of glioblastoma (GBM), has received approval for its Investigational New Drug (IND) application from the Center for Drug...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IND","BK1191","02637","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651127121","title":"Haisco Pharmaceutical's China IND Application for Novel Inflammatory Drug Accepted","url":"https://stock-news.laohu8.com/highlight/detail?id=2651127121","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651127121?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:09","pubTimestamp":1784005753,"startTime":"0","endTime":"0","summary":"Haisco Pharmaceutical  said China's medical products regulator has accepted the investigational new drug application for HSK60002 tablets.The drug was independently developed for treating inflammatory diseases, according to a Tuesday filing with the Shenzhen bourse.Shares of the company fell 1% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0188","002653","IND","BK0028","BK0033","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651147194","title":"Neurotech Secures FDA IND Clearance for NTI164, Bolstering Global ASD Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2651147194","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651147194?lang=en_us&edition=fundamental","pubTime":"2026-07-14 07:21","pubTimestamp":1783984875,"startTime":"0","endTime":"0","summary":"Neurotech International ( ($AU:NTI) ) has provided an update. Neurotech International has secured U.S. FDA clearance for its Investigational New Dr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurotech-secures-fda-ind-clearance-for-nti164-bolstering-global-asd-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurotech-secures-fda-ind-clearance-for-nti164-bolstering-global-asd-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585","IND","ASD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111171","title":"Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111171","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111171?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:01","pubTimestamp":1783944060,"startTime":"0","endTime":"0","summary":"- Data presented as Developing Topics poster at AAIC 2026 - LEXINGTON, Mass., July  13, 2026  (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to levera","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/13/3326162/36461/en/Voyager-Demonstrates-Single-IV-Dose-of-VY1706-Well-Tolerated-Reduced-Tau-in-6-Month-GLP-Toxicology-Study-Initiation-of-Clinical-Trial-in-Alzheimer-s-Disease-Expected-H2-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","NHP","IDNA","BK4132","IND","BK4225","BK4110","CNS","AD","BK4135","HYLG","BK4144","BBB","AAIC","GDOC","MEDX","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133045648","title":"Market Participants Report Indian Central Bank's Dollar Sales to Support Rupee","url":"https://stock-news.laohu8.com/highlight/detail?id=1133045648","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133045648?lang=en_us&edition=fundamental","pubTime":"2026-07-13 12:50","pubTimestamp":1783918242,"startTime":"0","endTime":"0","summary":"According to multiple unnamed trading sources with knowledge of the matter, the Reserve Bank of India has been selling dollars in the onshore foreign exchange market to bolster the rupee's value. The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDE","SCIN","IMVP","UDN","FLIN","INDY","IOPP","SMIN","INDA","EPI","INQQ","NFTY","UUP","NDIA","INCO","INDL","PIN","BK4523","BK4585","IND","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651207161","title":"Abbisko Wins FDA IND Clearance for Pan-KRAS Cancer Drug ABSK211","url":"https://stock-news.laohu8.com/highlight/detail?id=2651207161","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651207161?lang=en_us&edition=fundamental","pubTime":"2026-07-13 08:08","pubTimestamp":1783901304,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited ( ($HK:2256) ) has issued an update. Abbisko Therapeutics has received clearance from the U.S. Food and Drug Administration ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-fda-ind-clearance-for-pan-kras-cancer-drug-absk211?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-fda-ind-clearance-for-pan-kras-cancer-drug-absk211?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651146902","title":"Global funds return to Indian stocks with US$1 bil in buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2651146902","media":"Ashutosh Joshi / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651146902?lang=en_us&edition=fundamental","pubTime":"2026-07-13 06:09","pubTimestamp":1783894143,"startTime":"0","endTime":"0","summary":"Foreign investors poured more than US$1 billion into Indian equities last week.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/india/global-funds-return-indian-stocks-us1-bil-buying?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/india/global-funds-return-indian-stocks-us1-bil-buying?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["FLIN","INDY","SCIN","BK4585","SMIN","BK4588","NFTY","EPI","INDA","IND","INDL","BK4523","PIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650139262","title":"India Ratings Upgrades Vadilal Industries’ Credit Profile to IND A+","url":"https://stock-news.laohu8.com/highlight/detail?id=2650139262","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650139262?lang=en_us&edition=fundamental","pubTime":"2026-07-10 23:54","pubTimestamp":1783698887,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Vadilal Industries Limited ( ($IN:VADILALIND) ). India Ratings and Research has upgraded Vadilal Industries Lim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/india-ratings-upgrades-vadilal-industries-credit-profile-to-ind-a?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/india-ratings-upgrades-vadilal-industries-credit-profile-to-ind-a?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND","MNDmain"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}